Clinuvel Pharmaceuticals Limited Stock Xetra
Stocks
UR9
AU000000CUV3
Pharmaceuticals
OTC Markets Traded|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.282 EUR | 0.00% |
|
0.00% | - |
| 16/06 | Clinuvel Pharmaceuticals Advances US Listing Plan With SEC Filing for Nasdaq ADS Upgrade | MT |
| 28/04 | Clinuvel Pharmaceuticals plans level II ADR upgrade and Nasdaq listing as CUVL | RE |
| Market Cap | 517M 358M 313M 288M 268M 509M 34.13B 3.46B 1.34B 16.78B 1.35B 1.32B 57.81B | P/E 2026 * |
14.4x | P/E 2027 * | 13.5x |
|---|---|---|---|---|---|
| Enterprise Value | 263M 183M 160M 147M 137M 259M 17.38B 1.76B 684M 8.54B 685M 670M 29.44B | EV / Sales 2026 * |
2.65x | EV / Sales 2027 * | 2.19x |
| Free-Float |
83.79% | Yield 2026 * |
0.6% | Yield 2027 * | 0.78% |
Last Transcript: Clinuvel Pharmaceuticals Limited
| Manager | Title | Age | Since |
|---|---|---|---|
Philippe Wolgen
CEO | Chief Executive Officer | 63 | 01/11/2005 |
Peter Vaughan
DFI | Director of Finance/CFO | 42 | 30/06/2024 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Karen Agersborg
BRD | Director/Board Member | - | 29/01/2018 |
Susan Smith
BRD | Director/Board Member | - | 23/09/2019 |
| Chairman | - | 01/01/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | - | - | 359M | |
| +4.73% | +5.50% | +19.45% | -8.94% | 66.56B | |
| -1.93% | +0.39% | +58.62% | +226.33% | 57.64B | |
| +1.07% | +42.10% | +42.10% | +42.10% | 42.24B | |
| +3.45% | +3.54% | -49.20% | -56.09% | 39.09B | |
| -4.05% | +7.01% | +62.26% | -24.13% | 31.91B | |
| -1.99% | +33.49% | +163.41% | -34.35% | 31.65B | |
| -0.28% | +8.68% | +71.42% | +87.73% | 23.35B | |
| +2.87% | +15.37% | +10.72% | +196.62% | 18.92B | |
| -0.13% | +2.75% | +67.48% | +130.07% | 17.17B | |
| Average | +2.58% | +7.39% | +49.59% | +62.15% | 36.5B | |
| Weighted average by Cap. | +2.77% | +6.50% | +44.79% | +55.34% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 99.46M 68.98M 60.3M 55.42M 51.65M 97.97M 6.57B 665M 259M 3.23B 259M 253M 11.12B | 105M 73.07M 63.88M 58.7M 54.72M 104M 6.96B 705M 274M 3.42B 274M 268M 11.78B |
| Net income | 35.97M 24.94M 21.81M 20.04M 18.68M 35.43M 2.38B 241M 93.52M 1.17B 93.63M 91.62M 4.02B | 38.2M 26.49M 23.16M 21.28M 19.84M 37.63M 2.52B 256M 99.33M 1.24B 99.44M 97.31M 4.27B |
| Net Debt | -254M -176M -154M -141M -132M -250M -16.75B -1.7B -660M -8.23B -660M -646M -28.38B | -286M -198M -173M -159M -149M -282M -18.89B -1.91B -744M -9.28B -745M -729M -31.99B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- CUV Stock
- UR9 Stock
Select your edition
All financial news and data tailored to specific country editions
